TEVA PHARM INDUS (TEVJF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 8 10 sessions, August 8, 2025 to July 21, 2026
- Largest daily move
- +54.6% close of December 9, 2025
Company Description
TEVA PHARM INDUS (OTC: TEVJF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $33.1B.
TEVJF has declined 0.7% so far this year. The last closing price was $28.40.
For FY2025, TEVA PHARM INDUS reported revenue of $17.3B with net income of $1.4B and diluted earnings per share of $1.21. The company operates at a net profit margin of 8.2%.
This page collects what Stock Titan holds for TEVJF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
TEVA PHARM INDUS (TEVJF) closed at $28.40 on July 21, 2026. So far this year, the price has lost 0.7%.
TEVJF Metrics & Rankings
Price returns through July 21, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
TEVA PHARM INDUS has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form 25-NSE, 1 Form 424B5. The most recent filing was submitted on September 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TEVJF SEC filings →
Financial Highlights
TEVA PHARM INDUS generated $17.3B in revenue in FY2025, retaining a 51.8% gross margin, operating income reached $2.2B (12.5% operating margin), and net income was $1.4B, reflecting a 8.2% net profit margin. Diluted earnings per share stood at $1.21. The company generated $1.6B in operating cash flow. With a current ratio of 1.04, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in TEVA PHARM INDUS (TEVJF) currently stands at 272.1 thousand shares, up 14.1% from the previous reporting period, representing 0.0% of the float. Since September 2025, short interest has decreased by 89.1%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for TEVA PHARM INDUS (TEVJF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges.
TEVJF Company Profile & Sector Positioning
TEVA PHARM INDUS (TEVJF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.